Search Results

Reports Outline Coronavirus Findings from Regeneron Pharmaceuticals Inc. (Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications To Clinical Development)

• Source: Obesity, Fitness & Wellness Week. February 10, 2024, 104

Record details

Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development.

• Authors : Davis JD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Bravo Padros M

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/adverse effects ; Subcutaneous Tissue*; Humans

• Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Mar; Vol. 115 (3), pp. 422-439. Date of Electronic Publication: 2024 Jan 10.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Reports Outline Coronavirus Findings from Regeneron Pharmaceuticals Inc. (Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications To Clinical Development).

• Source: Drug Week; 2/6/2024, p1532-1532, 1p

Record details

Preclinical Testing of Antibodies: Pharmacology, Kinetics and Immunogenicity.

• Authors : Rehm, H.-J.; Reed, G.

• Source: Biotechnology Set; 2001, p289-302, 14p

Record details

Preclinical Testing of Antibodies: Pharmacology, Kinetics and Immunogenicity.

• Authors : Rehm, H.-J.; Reed, G.

• Source: Biotechnology: A: Recombinant Proteins, Monoclonal Antibodies & Therapeutic Genes (9783527283156); 1998, p289-302, 14p

Record details

Agricola

Record details

Agricola

Record details

Agricola

Record details

Agricola

Record details

Agricola

Record details